Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026)
Zymeworks (ZYME) posted Exchange Rate Effect of $98000.0 for Q1 2026, up 322.73% sequentially from -$44000.0 in Q4 2025, and up 880.0% YoY from $10000.0 in Q1 2025.
Powered by 
Analysis
Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Zymeworks has reported Exchange Rate Effect for 6 years, with the latest figure at $98000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 880.0% year-over-year to $98000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (down 75.71% YoY) and the FY2025 annual result came in at -$45000.0, down 115.73% from the prior year.
- Exchange Rate Effect grew to $98000.0 in Q1 2026 per ZYME's latest filing, from -$44000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $346000.0 in Q1 2023 and troughed at -$123000.0 in Q1 2022.
- A 5-year average of $52705.9 and a median of $23000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect soared 3866.67% in 2024, then plunged 241.94% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$88000.0 in 2022, then surged by 96.59% to -$3000.0 in 2023, then jumped by 3866.67% to $113000.0 in 2024, then tumbled by 138.94% to -$44000.0 in 2025, then surged by 322.73% to $98000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $98000.0, -$44000.0, and $77000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - | 24,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | -12,000.00 |
| Mar 31, 2023 | 346,000.00 |
| Dec 31, 2022 | -88,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 166,000.00 |
| Mar 31, 2022 | -123,000.00 |
| Dec 31, 2021 | 105,000.00 |